IgA1 Protease Treatment Reverses Mesangial Deposits and Hematuria in a Model of IgA Nephropathy-Reference-Cited by-同舟云学术

IgA1 Protease Treatment Reverses Mesangial Deposits and Hematuria in a Model of IgA Nephropathy

Published:2016-02-05 Issue:9 Volume:27 Page:2622-2629
ISSN:1046-6673
Container-title:Journal of the American Society of Nephrology
language:en
Short-container-title:JASN

Author:

Lechner Sebastian M.,Abbad Lilia,Boedec Erwan,Papista Christina,Le Stang Marie-Bénédicte,Moal Christelle,Maillard Julien,Jamin Agnès,Bex-Coudrat Julie,Wang Yong,Li Aiqun,Martini Paolo G.V.,Monteiro Renato C.,Berthelot Laureline

Publisher

American Society of Nephrology (ASN)

Subject

Nephrology,General Medicine

Reference31 articles.

1. Recurrence of mesangial deposition of IgA after renal transplantation

2. IgA Nephropathy

3. Role of Aberrant Glycosylation of IgA1 Molecules in the Pathogenesis of IgA Nephropathy

4. Aberrantly glycosylated IgA1 as a factor in the pathogenesis of IgA nephropathy.;Tanaka;Clin Dev Immunol,2011

5. Fcα Receptor (Cd89) Mediates the Development of Immunoglobulin a (Iga) Nephropathy (Berger's Disease)

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The pathogenesis of IgA nephropathy and implications for treatment;Nature Reviews Nephrology;2024-09-04

2. Lipid Nanoparticle-Mediated Delivery of mRNA Into the Mouse and Human Retina and Other Ocular Tissues;Translational Vision Science & Technology;2024-07-09

3. Drugs in Development to Treat IgA Nephropathy;Drugs;2024-05

4. Microscopic hematuria as a risk factor for IgAN progression: considering this biomarker in selecting and monitoring patients;Clinical Kidney Journal;2023-12

5. Lipid nanoparticle-mediated delivery of mRNA into the mouse and human retina and other ocular tissues;2023-07-13